Clinical Trials Browser

Vipoma, Glucagonoma, Insulinoma, Adenoma, Islet Cell, Lung Neoplasms, Neoplasms, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell, Neuroendocrine Tumors

NCT01905657 2021-10-06

MK-3475-010

Phase 2/3 Completed

1,034 enrolled 16 charts

Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT02195232 2021-03-03

CATIQ

Phase 2/3 Completed

64 enrolled 7 charts

GastrointestinalThoracic

Thromboembolism of Vein VTE in Colorectal Cancer

NCT03098030 2020-12-09

Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer

Phase 2/3 Completed

483 enrolled 19 charts

Thoracic

Small Cell Lung Carcinoma

NCT02186301 2019-05-07

EGFR

Phase 2/3 Terminated

100 enrolled 14 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Recurrence

NCT01907100 2019-03-18

Nintedanib (BIBF 1120) in Mesothelioma

Phase 2/3 Terminated

545 enrolled 15 charts

Other solid neoplasmThoracic

Mesothelioma

NCT01446874 2018-11-08

POPP

Phase 2/3 Terminated

150 enrolled 11 charts

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms

NCT00473889 2015-07-03

A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056)

Phase 2/3 Terminated

253 enrolled 13 charts

Thoracic

Stage IIIB or IV Non-Small Cell Lung Cancer

NCT01761747 2014-12-23

Ponatinib for Squamous Cell Lung and Head and Neck Cancers

Phase 2/3 Terminated

3 enrolled 9 charts

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00527722 2012-08-07

Evaluation of the Bio-Seal Biopsy Track Plug

Phase 2/3 Completed

77 enrolled 4 charts

Thoracic

Lung Neoplasms

NCT01259284 2012-08-07

Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer

Phase 2/3 Terminated

2 enrolled 4 charts

BreastDermatologicGastrointestinalHead & NeckSarcomaThoracic

Breast Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Sarcoma, Urogenital Neoplasms, Colorectal Neoplasms

Clinical Trials

Tenecteplase (TNK) for Loculated Pleural Effusions in Patients With Malignancy

Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer

S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer

Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma

ATOMIC

Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors

MK-3475-010

CATIQ

Dinutuximab and Irinotecan Versus Irinotecan to Treat Subjects With Relapsed or Refractory Small Cell Lung Cancer

EGFR

Nintedanib (BIBF 1120) in Mesothelioma

POPP

A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056)

Ponatinib for Squamous Cell Lung and Head and Neck Cancers

Evaluation of the Bio-Seal Biopsy Track Plug

Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer